Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Menu
Subscribe
Home
Promote Your Event
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscription Services
Local Weather
News
Local News
Sports
Entertainment
Obituaries
Local Events
Photos
Videos
e-Edition
Classifieds
Place an ad
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Fulgent Genetics Inc
(NQ:
FLGT
)
39.77
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 31, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
39.77
Bid (Size)
27.77 (2)
Ask (Size)
43.75 (1)
Prev. Close
39.77
Today's Range
39.77 - 39.77
52wk Range
28.27 - 65.17
Shares Outstanding
29,701,246
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Better Diversified Biotech Stock: 23andMe vs. Fulgent Genetics
May 23, 2023
Neither has a traditional business model, but that could be an asset for both.
Via
The Motley Fool
2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years
May 23, 2023
Both are experiencing a bit of a hangover from declining COVID-19-related sales.
Via
The Motley Fool
Performance
YTD
+29.71%
+29.71%
1 Month
+33.01%
+33.01%
3 Month
+24.87%
+24.87%
6 Month
+9.65%
+9.65%
1 Year
-27.04%
-27.04%
More News
Read More
Fulgent Genetics Earnings Perspective: Return On Capital Employed
May 19, 2023
Via
Benzinga
Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2023 Annual Meeting
May 18, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 05, 2023
Via
Benzinga
Fulgent Genetics: Q1 Earnings Insights
May 05, 2023
Via
Benzinga
Preview: Fulgent Genetics's Earnings
May 04, 2023
Via
Benzinga
Looking Into Fulgent Genetics's Return On Capital Employed
March 06, 2023
Via
Benzinga
Where Fulgent Genetics Stands With Analysts
December 08, 2022
Via
Benzinga
Fulgent Reports First Quarter 2023 Financial Results
May 05, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Earnings Scheduled For May 5, 2023
May 05, 2023
Via
Benzinga
5 Value Stocks In The Healthcare Sector
December 05, 2022
Via
Benzinga
Fulgent Genetics to Announce First Quarter 2023 Financial Results on Friday May 5, 2023
April 20, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
7 Stocks to Buy to Bag Big-Time Returns in Q2
April 16, 2023
Via
InvestorPlace
Fulgent Reports Fourth Quarter and Full Year 2022 Financial Results
February 28, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Genetics Launches New Beacon787 Expanded Carrier Screening Panel
February 28, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent to Participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference
February 23, 2023
From
Fulgent, Inc.
Via
Business Wire
Fulgent Genetics to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023
February 14, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
NASDAQ:FLGT Long Term Investor Alert: Investigation of Potential Wrongdoing at Fulgent Genetics, Inc.
February 09, 2023
Via
SBWire
FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
January 13, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – FLGT
January 10, 2023
From
Scott+Scott Attorneys at Law LLP
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
January 06, 2023
Via
Benzinga
Fulgent Expands Board of Directors with Addition of Reggie Groves
January 03, 2023
From
Fulgent Genetics, Inc.
Via
Business Wire
Which Is the Better Buy: Vertex or Invitae?
December 16, 2022
Via
The Motley Fool
My Top 7 Strong Conviction Buys for 2023
December 15, 2022
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.